What Happens When Proton Meets Randomization: Is There a Future for Proton Therapy?

被引：8

作者：

Kong, Feng-Ming ^{[1
]}

机构：

[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 18期

关键词：

CELL LUNG-CANCER; PHOTON RADIATION-THERAPY; COST-EFFECTIVENESS; PHASE-III; RADIOTHERAPY; CONCURRENT; CISPLATIN; ETOPOSIDE; TRIALS; RISK;

D O I：

10.1200/JCO.2017.76.5479

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1777 / +

页数：5

共 19 条

[1] Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Bradley, Jeffrey D.
Paulus, Rebecca
Komaki, Ritsuko
Masters, Gregory
Blumenschein, George
Schild, Steven
Bogart, Jeffrey
Hu, Chen
Forster, Kenneth
Magliocco, Anthony
Kavadi, Vivek
Garces, Yolanda I.
Narayan, Samir
Iyengar, Puneeth
Robinson, Cliff
Wynn, Raymond B.
Koprowski, Christopher
Meng, Joanne
Beitler, Jonathan
Gaur, Rakesh
Curran, Walter, Jr.
Choy, Hak
[J]. LANCET ONCOLOGY, 2015, 16 (02) : 187 - 199
[2] High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
Farquhar, Cindy
Marjoribanks, Jane
Lethaby, Anne
Azhar, Maimoona
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (05):
[3] Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
Fisher, B
Anderson, S
Bryant, J
Margolese, RG
Deutsch, M
Fisher, ER
Jeong, J
Wolmark, N
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) : 1233 - 1241
[4] Proton beam therapy - Do we need the randomised trials and can we do them?
Glimelius, Bengt
Montelius, Anders
[J]. RADIOTHERAPY AND ONCOLOGY, 2007, 83 (02) : 105 - 109
[5] Should randomized clinical trials be required for proton radiotherapy?
Goitein, Michael
Cox, James D.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 175 - 176
[6] Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer: The Hoosier Oncology Group and US Oncology
Hanna, Nasser
Neubauer, Marcus
Yiannoutsos, Constantin
McGarry, Ronald
Arseneau, James
Ansari, Rafat
Reynolds, Craig
Govindan, Ramaswamy
Melnyk, Anton
Fisher, William
Richards, Donald
Bruetman, Daniel
Anderson, Thomas
Chowhan, Naveed
Nattam, Sreenivasa
Mantravadi, Prasad
Johnson, Cynthia
Breen, Tim
White, Angela
Einhorn, Lawrence
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) : 5755 - 5760
[7] National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer
Higgins, Kristin A.
O'Connell, Kelli
Liu, Yuan
Gillespie, Theresa W.
McDonald, Mark W.
Pillai, Rathi N.
Patel, Kirtesh R.
Patel, Pretesh R.
Robinson, Clifford G.
Simone, Charles B., II
Owonikoko, Taofeek K.
Belani, Chandra P.
Khuri, Fadlo R.
Curran, Walter J.
Ramalingam, Suresh S.
Behera, Madhusmita
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (01): : 128 - 137
[8] Jin JY, 2017, INT J RADIAT ONCOL, V99
[9] Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer A Phase 2 Clinical Trial
Kong, Feng-Ming
Ten Haken, Randall K.
Schipper, Matthew
Frey, Kirk A.
Hayman, James
Gross, Milton
Ramnath, Nithya
Hassan, Khaled A.
Matuszak, Martha
Ritter, Timothy
Bi, Nan
Wang, Weili
Orringer, Mark
Cease, Kemp B.
Lawrence, Theodore S.
Kalemkerian, Gregory P.
[J]. JAMA ONCOLOGY, 2017, 3 (10) : 1358 - 1365
[10] Nondosimetric Risk Factors for Radiation-Induced Lung Toxicity
Kong, Feng-Ming
Wang, Shulian
[J]. SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 100 - 109

← 1 2 →